Anu Mahajan

Anu Mahajan

Auto-generated profile, based on publicly available information

Anu Mahajan

Symbiosis International (Deemed University)

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2026 in iScience
Verified
Journal Article
Open access
AMAnu Mahajan
Anu Mahajan
JSJhanvee Shah
Jhanvee Shah
AMArti S. Muley
Arti S. Muley
The study compares the effectiveness of yoga practice duration in managing type 2 diabetes (T2D) among the Asian population. Out of 664 results, 22 randomized clinical trials were identified with 1,720 participants, aged 18–65 years, with intervention periods ranging from 5.5 to 24 weeks. Yoga therapies of ≥12 weeks show significant decrease in glycated hemoglobin (HbA1c) levels (Standard Mean Deviation [SMD] = −0.70, p = 0.0001, I2 = 89%), while interventions of <12 weeks did not have statistically significant difference (SMD = −1.04, p = 0.28, I2 = 93%). Weight loss was significant for interventions <12 weeks (SMD = −0.60, p = 0.05, I2 = 0%) but not for those ≥12 weeks (SMD = −0.58, p = 0.17, I2 = 92%). Lipid profile changes varied, with significant reductions in the lipid profile (total cholesterol) (SMD = −0.34, p = 0.05, I2 = 85%) and low-density lipoprotein (LDL; SMD = −0.30, p = 0.05, I2 = 79%) for interventions of ≥12 weeks, while high-density lipoprotein (HDL; SMD = 0.37, p = 0.04, I2 = 85%) increased significantly in this group. Yoga interventions of ≥12 weeks were associated with significant improvements in glycemic control, particularly reductions in HbA1c, along with favorable changes in the lipid profile, among T2D individuals.

2 June 2026 in Nutrition and Health
Verified
Journal Article
Open access
AMAnu Mahajan
Anu Mahajan
AMArti S. Muley
Arti S. Muley
Background: Women living with type 2 diabetes mellitus (T2DM) often encounter unique physiological and lifestyle-related hurdles that impact disease progression and management. Dietary interventions tailored to cultural and gender-specific needs are essential for effective diabetes management. Aim: This pilot trial primarily evaluated feasibility and safety and, secondarily, explored the preliminary metabolic effects and practical implementation of a lacto-vegetarian diet combined with intermittent fasting in Indian women with T2DM. Methods: In this 12-week, parallel-group, open-label randomized controlled trial, 10 women with T2DM (aged 25–60 years) were randomly allocated in a 1:1 ratio using block randomization to either an intervention group (lacto-vegetarian diet within a 10-h eating window) or a control group (usual diet). Glycemic, lipid, and anthropometric parameters were measured at baseline and after the intervention. Safety, tolerability, and participant-reported experiences were also assessed. Results: Exploratory within-group analyses in the intervention arm demonstrated reductions in glycated hemoglobin (−11.3%), fasting insulin (−47.4%), body weight (−3.96.0%), and body mass index (−3.98%) while the control group showed no meaningful changes. Lipid parameters showed no meaningful changes. No serious adverse events occurred; mild fatigue, hypoglycemia, and constipation were reported but resolved without intervention. Participants expressed improvements in energy, appetite control, and emotional well-being. No reductions in diabetes medication were reported, likely due to the short duration of the intervention. Conclusion: This pilot randomized controlled trial was feasible, safe, and well-tolerated and showed signals of potential metabolic benefit in women with T2DM. This pilot study is part of an ongoing clinical trial, and the complete results will be presented upon completion of the full trial.

30 April 2026 in Precision Nutrition
Verified
Journal Article
Open access
JSJhanvee Shah
Jhanvee Shah
AMAnu Mahajan
Anu Mahajan
AMArti S. Muley
Arti S. Muley
Background: To critically evaluate the biological and epigenetic pathways through which pranayama may influence metabolic regulation relevant to the prevention and management of type 2 diabetes mellitus. This review also synthesizes mechanistic findings across oxidative stress pathways, mitochondrial bioenergetics, inflammatory signaling, cortisol dynamics, and autonomic regulation to analyze how breath-based interventions may modulate diabetes-related molecular and physiological processes. Methods: Databases were searched for the decade 2014–2024 using the Keywords “Pranayama,” or “Pranayama therapy,” and “Oxidative stress,” and “Mitochondrial function,” and “cortisol,” and “Autonomic nervous system,” in combination with “Type 2 Diabetes” or “Diabetes Mellitus.” The review aimed to provide a comprehensive discussion of the current topic and, thus, does not include any specific data synthesis. Results: Current literature demonstrates that pranayama modulates several biological pathways implicated in both the development and management of type 2 diabetes. Studies report reductions in reactive oxygen species (ROS) and improvements in total antioxidant capacity (TAC), indicating enhanced regulation of oxidative stress. Improved NAD + levels and COX-II activity suggest a positive influence on mitochondrial function. Additionally, pranayama has been shown to lower cortisol levels and C-reactive protein (CRP) while improving autonomic balance, all of which are associated with improved insulin sensitivity and glycemic control. Conclusions: By mitigating oxidative stress, enhancing mitochondrial efficiency, modulating inflammation, lowering stress-related cortisol secretion, and improving autonomic nervous system tone, pranayama may support both the prevention and management of type 2 diabetes. Future randomized controlled trials are warranted to further validate these mechanisms and clinical outcomes.